Kumiko Kagawa
Associate Professor
Faculty of Medicine
University of Tokushima
Japan
Biography
Kumiko Kagawa has done his Doctor of Medicine from Tokushima University. Currently he is working as Associate Professor in Faculty of Medicine at Tokushima University. His research interests are Medicine, Clinical Immunology, Haematology. Several papers of his work were pubished in reputed international journals. He is also the member of several governing bodies of his specialization.
Research Interest
Medicine, Clinical Immunology, Haematology.
Publications
-
Hirokazu Miki, Shingen Nakamura, A Oda, R Amachi, Keiichiro Watanabe, D Hanson, Jumpei Teramachi, Masahiro Hiasa, H Yagi, K Sogabe, M Takahashi, T Maruhashi, K Udaka, T Harada, Shiroh Fujii, A Nakano, Kumiko Kagawa, M Ri, S Iida, Shuji Ozaki, T Matsumoto and Masahiro Abe. Induction of endoplasmic reticulum stress by bortezomib sensitizes myeloma cells to DR5-mediated cell death. International Journal of Myeloma. 2015, 5(1): 1-7.
-
Takeshi Harada, Hirokazu Miki, Q Cui, A Oda, Ryota Amachi, Jumpei Teramachi, A Bat-Erdene, K Sogabe, M Iwasa, Shiroh Fujii, Shingen Nakamura, Kumiko Kagawa, Sumiko Yoshida, I Endo, Ken-ichi Aihara, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe. Expansion of Th1-like V9V2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid. Leukemia. 2016, 31(1): 258-262.
-
Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Takeshi Harada, Shingen Nakamura, Ryota Amachi, Hirofumi Tenshin, Masami Iwasa, Shiroh Fujii, Kumiko Kagawa, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe. Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma. British Journal of Haematology, 2016.
